Thus, our study shows that VDAC1 depletion represents a trigger for reprogramming malignant cancer cells into a post-mitotic state and probably into terminally differentiated cells, and that this might be a promising therapeutic approach for mesothelioma and various cancers. This evidence concerns the gene VDAC1 and cancer.